Ilant founder and CEO Elina Onitskansky
June 2, 2026 06:00 AM EDT
FinancingStartupsHealth Tech
Exclusive: Obesity care startup Ilant Health raises $15M
Shelby Livingston
Ilant Health has raised a $15M Series A funding round to expand its personalized approach to treating obesity.
Ilant Health closes $15M Series A for personalized obesity care, capitalizing on GLP-1 drug boom. Signal for tech leads: obesity shifts from pharma-only to persistent tech platforms requiring AI decision support and EHR integration—healthcare IT budgets expand.
Ilant founder and CEO Elina Onitskansky
June 2, 2026 06:00 AM EDT
FinancingStartupsHealth Tech
Exclusive: Obesity care startup Ilant Health raises $15M
Shelby Livingston

Lilly shares safety, tolerability data on its next-gen obesity drug

Althera atrai 15 mil interessados e testa modelo enxuto com IA para tratar obesidade no Brasil

Eli Lilly’s (LLY) New Drug Gives Investors a Wake-Up Call as Data Bolsters the Stock’s Growth Story

Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on…

Signos, a startup that aims to help people lose weight by understanding their blood sugar, has raised a new $20 million round of…

Can any of the new obesity medications in development stand out from the pack? Which company just broke records with its IPO? And…

Virtual care platform First Stop Health unveiled an expansion of its Healthy Weight Program amid increasing GLP-1 demand and…

Employers can use Lilly's platform to connect with different third-party program administrators that help manage obesity…

Eli Lilly presented new safety and tolerability data on retatrutide at the annual meeting of the American Diabetes Association on…